If the CV% between duplicate determinations of only one Marker  (IGF-I or P -III-NP) exceeds the respective uc_Max, the analysis of only that Marker  shall be repeated;        ABP Operating Guidelines  – Version 9.0 – July 2023  Page 37/91 − The mean Marker concentration from the duplicate measurement of IGF- I and P -III-NP shall be reported in ADAMS  in nanograms per milliliters (ng/mL);  − If the measured Marker concentration is below the LOQ of the assay, the Laboratory  shall report a value of “ -1” for its concentration in ADAMS and the Laboratory  shall make a comment in the Test Report on why the Marker  could not be quantified (e.g., the measurement of the Marker  is not possible due to unusual matrix interferences);  − An observation of hemolysis of the Sample  should be recorded in the comments section of the Laboratory  Test Report in ADAMS.